Bass James Edward 4
4 · REATA PHARMACEUTICALS INC · Filed Jun 14, 2018
Insider Transaction Report
Form 4
Bass James Edward
Director
Transactions
- Award
Stock Option (right to buy)
2018-06-13+8,000→ 8,000 totalExercise: $39.48Exp: 2028-06-13→ Class B common stock (8,000 underlying) - Award
Stock Option (right to buy)
2018-06-13$26.49/sh+693$18,358→ 693 totalExercise: $39.48Exp: 2028-06-13→ Class B common stock (693 underlying)
Footnotes (3)
- [F1]The options vest in 4 equal installments on September 13, 2018, December 13, 2018, March 13, 2019, and June 13, 2019, subject to continued service through each vesting date.
- [F2]The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date.
- [F3]This option was issued to the reporting person pursuant to the Reata Non-Employee Director Compensation Policy in lieu of future director fees of $18,375.00